On October 14, 2025, InMed Pharmaceuticals appointed Mr. John Bathery to its Board of Directors and increased the board size to six members, while Mr. Bryan Baldasare will not seek re-election due to professional obligations on October 15, 2025. The appointment may include committee assignments and Mr. Bathery will earn an annual retainer of $50,000.